Kodiak Sciences (KOD) Equity Average (2018 - 2026)
Kodiak Sciences filings provide 9 years of Equity Average readings, the most recent being $134.7 million for Q1 2026.
- Quarterly Equity Average rose 4.0% to $134.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $134.7 million through Mar 2026, up 4.0% year-over-year, with the annual reading at $153.8 million for FY2025, 26.05% down from the prior year.
- Equity Average hit $134.7 million in Q1 2026 for Kodiak Sciences, up from $90.5 million in the prior quarter.
- Across five years, Equity Average topped out at $630.4 million in Q1 2022 and bottomed at $47.0 million in Q3 2025.
- Average Equity Average over 5 years is $287.2 million, with a median of $253.5 million recorded in 2024.
- The largest annual shift saw Equity Average plummeted 76.5% in 2025 before it rose 4.0% in 2026.
- Kodiak Sciences' Equity Average stood at $457.8 million in 2022, then crashed by 37.95% to $284.1 million in 2023, then tumbled by 40.93% to $167.8 million in 2024, then plummeted by 46.05% to $90.5 million in 2025, then surged by 48.82% to $134.7 million in 2026.
- Per Business Quant, the three most recent readings for KOD's Equity Average are $134.7 million (Q1 2026), $90.5 million (Q4 2025), and $47.0 million (Q3 2025).